GlassScriptPhysician profile
Walter J Chun
NPI 1710912050
$1,566.09
in general payments reported to CMS, 2019-2025
20 companies · $248 in 2025
The $248 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $67.27 · 2021: $170 · 2022: $219 · 2023: $248 · 2024: $337 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $184.39 | 2022-2025 | Qelbree, Qelbree |
| Corium, LLC | $172.02 | 2022-2025 | Azstarys |
| Cranial Technologies, INC | $170.50 | 2019-2023 | Doc Band |
| Kaleo, INC. | $156.21 | 2019-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $147.01 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $114.57 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $99.26 | 2019-2024 | Bexsero, Rotarix |
| Pfizer INC. | $79.31 | 2019-2023 | |
| Qol Medical, LLC | $76.39 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $70.61 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $61.15 | 2022-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Tris Pharma INC | $51.84 | 2019-2022 | |
| Genentech USA, INC. | $46.07 | 2019-2020 | |
| Verrica Pharmaceuticals INC. | $24.38 | 2023 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $24.04 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $23.01 | 2021 | |
| Welch Allyn | $21.95 | 2020 | |
| Alk-Abello, INC | $17.39 | 2025 | Neffy |
| Mission Pharmacal Company | $13.94 | 2019 | |
| Sanofi Pasteur INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Chun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.